FREE SHIPPING on orders over $59 | 100% Happiness Guarantee | 📞 877-564-5756 | ✉️ info@bioabsorbnutraceuticals.com

Does Melatonin Affect Blood Pressure?

by Dave Kimbell

📅 Last Updated: April 07, 2026

Does Melatonin Affect Blood Pressure?

If you're considering melatonin for sleep but have concerns about your cardiovascular health, you've likely wondered: does melatonin affect blood pressure? The answer is more nuanced than a simple yes or no. Research shows that repeated melatonin intake reduces nocturnal systolic and diastolic blood pressure by 6 and 4 mm Hg respectively in people with hypertension, but the effect differs significantly depending on your baseline blood pressure, dosage, and how long you take it. For most healthy adults, melatonin appears safe—but there are important context-specific considerations, especially if you're already on blood pressure medication.

This article breaks down the clinical evidence on melatonin and blood pressure, explaining what happens at the cellular level, who benefits most, and what you need to know before supplementing.

Table of Contents:

  1. How Melatonin Affects Blood Pressure: The Science
  2. Melatonin's Impact in Hypertensive Populations
  3. Melatonin and Blood Pressure in Healthy Adults
  4. Dosage, Timing, and Duration: What Matters
  5. Drug Interactions and Safety Concerns
  6. BioAbsorb Liposomal Melatonin and Cardiovascular Health
  7. FAQ: Melatonin and Blood Pressure

How Melatonin Affects Blood Pressure: The Science

Melatonin influences blood pressure through multiple overlapping mechanisms, not just one. The hormone works primarily through two receptor types—MT1 and MT2—which exist on blood vessel walls and the cells lining arteries (endothelial cells). When MT2 receptors are activated, they stimulate nitric oxide (NO) production in endothelial cells, triggering vasodilation—the relaxation and widening of blood vessels. This cascade reduces vascular resistance, allowing blood to flow more easily and pressure to drop. In contrast, MT1 receptor activation protects the vascular endothelium from oxidative stress and reduces inflammation through its antioxidant properties, both of which support healthy blood vessel function.

Beyond vasodilation, melatonin activates large-conductance calcium-activated potassium (BKCa) channels on vascular smooth muscle cells, further promoting relaxation and reducing arterial stiffness. The hormone also modulates the renin-angiotensin-aldosterone system (RAAS), a key regulator of blood volume and pressure, and reduces sympathetic nervous system activity—the "fight or flight" response that elevates BP. These mechanisms explain why melatonin's blood pressure effect is tied to its circadian regulation function; as the pineal gland releases melatonin at night, it simultaneously prepares blood vessels to relax and support restorative sleep.

Key mechanisms include:

Melatonin's Impact in Hypertensive Populations

The strongest evidence for melatonin's blood pressure-lowering effect comes from studies of people with hypertension. A landmark 2004 randomized controlled trial of 16 men with untreated essential hypertension found that 2.5 mg of melatonin taken daily for 3 weeks reduced systolic BP by 6 mm Hg and diastolic BP by 4 mm Hg during sleep. This reduction is clinically meaningful; a decrease of 6 mm Hg is comparable to the effect of many standard antihypertensive medications, and even 2–3 mm Hg reductions have clear cardiovascular benefits. Importantly, a single dose produced no effect, indicating that chronic, repeated supplementation is necessary.

A 2019 meta-analysis of 8 randomized controlled trials specifically in people with metabolic disorders (diabetes, metabolic syndrome) found that melatonin supplementation significantly reduced both systolic and diastolic blood pressure, with standardized effect sizes of −0.42 and −0.50 respectively. The benefit appears most pronounced in nocturnal hypertension—elevated nighttime BP—which is a significant cardiovascular risk factor. However, effect magnitude varies by dosage, treatment duration, and individual baseline BP, which explains why some studies show larger reductions than others.

For people with hypertension specifically, BioAbsorb's liposomal melatonin achieves 80–95% bioavailability compared to 15–20% for standard tablets, meaning your body actually absorbs and uses significantly more of each dose. This enhanced absorption may be particularly relevant when trying to achieve consistent, measurable BP reductions. BioAbsorb formulations use GMP-certified manufacturing and are Health Canada-approved, providing confidence in quality and consistency—important factors when managing cardiovascular health.

Melatonin and Blood Pressure in Healthy Adults

The picture is less clear—but still encouraging—for people with normal baseline blood pressure. A study of 21 normotensive young adults found that chronic 5 mg melatonin intake for 4 weeks decreased 24-hour systolic BP by approximately 4.5 mm Hg and diastolic BP by 6.4 mm Hg (nighttime only). While the daytime effect was modest, the nocturnal reduction suggests that melatonin supports cardiovascular rest even in those without hypertension.

More recent research on 22 normotensive young adults found that 10 mg melatonin daily lowered nighttime peripheral and central systolic BP even when subjects consumed a high-sodium diet (6,900 mg/day sodium for 10 days). Notably, melatonin did not alter blood pressure reactivity—the exaggerated BP spikes in response to stress—but did lower baseline nighttime BP, suggesting a resting effect rather than a stress-buffering effect.

Conversely, a 2024 randomized controlled trial of 39 healthy postmenopausal women found no significant difference in blood pressure or arterial stiffness after 3 months of 10 mg melatonin daily compared to placebo, though the supplement was well-tolerated with no adverse effects. The lack of effect in this population may reflect differences in age, sex, or baseline cardiovascular resilience. Overall, healthy adults show modest but consistent nighttime BP reductions with melatonin, which may contribute to cardiovascular health over time even if the acute effect is small.

Dosage, Timing, and Duration: What Matters Most

Three factors determine whether melatonin will meaningfully affect your blood pressure: dose, timing, and how long you take it. The landmark hypertension study used 2.5 mg taken 1 hour before sleep and required 3 weeks of daily dosing to achieve the 6–4 mm Hg reduction. This suggests that effective melatonin supplementation is a cumulative, long-term strategy rather than an acute intervention. Single doses produced no effect on blood pressure, highlighting the importance of consistent daily use.

Dosage ranges vary widely in the research: studies used 5 mg in normotensive subjects, 10 mg in high-sodium diet stress testing, and 10 mg in postmenopausal women. There is no clear "optimal" dose for blood pressure management—response appears individual. BioAbsorb's liposomal melatonin provides 1.5 mg per full dropper with a graduated dropper allowing ~0.25 mg increments, enabling flexible dose titration to find your personal threshold.

Timing also matters. Studies administered melatonin 1 hour before sleep to align with natural circadian timing. This aligns with melatonin's physiological role—evening administration leverages the hormone's natural nocturnal surge to support both sleep and cardiovascular rest. Taking melatonin earlier in the day may disrupt circadian signaling and reduce effectiveness. For duration, treatment periods ranged from 3 weeks to several months in most trials, suggesting you should allow at least 3–4 weeks of consistent use before evaluating whether melatonin affects your personal blood pressure profile.

Drug Interactions and Safety Concerns

While melatonin is generally safe for short-term use, there is a critical drug interaction to be aware of. A double-blind study of 47 hypertensive patients on nifedipine (a calcium channel blocker) found that 5 mg melatonin taken in the evening for 4 weeks increased systolic BP by 6.5 mm Hg and diastolic BP by 4.9 mm Hg throughout the 24-hour period. This is the opposite of the desired effect and suggests that melatonin may interfere with calcium channel blocker efficacy. The researchers hypothesized competition between melatonin and nifedipine at the cellular level, impairing the medication's antihypertensive action.

Mayo Clinic warns that melatonin might worsen blood pressure in people taking blood pressure medications and recommends consulting a healthcare provider before combining melatonin with antihypertensive drugs. This does not mean you cannot use melatonin if you're on blood pressure medication, but it does mean you should discuss it with your doctor and monitor your BP closely. In particular, avoid combining melatonin with calcium channel blockers (nifedipine, diltiazem, verapamil) without medical supervision.

Regarding long-term safety, melatonin is generally considered safe when used for short-term purposes such as adjusting sleep patterns, but the long-term safety of melatonin supplements, especially in high doses, is still under research. Melatonin also has additive sedative effects with CNS depressants and may affect blood sugar if you take diabetes medications. Before starting any melatonin supplementation program, check with your healthcare provider about potential interactions with your specific medications.

BioAbsorb Liposomal Melatonin and Cardiovascular Health

If you're considering melatonin supplementation for cardiovascular support—whether for sleep quality or blood pressure regulation—the form and quality of the supplement matter significantly. BioAbsorb Liposomal Melatonin uses phospholipid encapsulation technology to achieve 80–95% bioavailability compared to 15–20% for standard melatonin tablets. This means that substantially more of each dose reaches your bloodstream and tissues where it can exert its cardiovascular effects. The liposomal formulation also has a faster onset (15–30 minutes vs. 60–90 minutes for tablets), allowing more precise timing to align with your bedtime routine and circadian rhythm.

BioAbsorb's melatonin is available in 5 mg and 10 mg liposomal liquid formulations, with a graduated dropper allowing fine-tuned dosing (approximately 0.25 mg increments per drop). This flexibility is valuable when experimenting with dose-response effects on blood pressure. Each batch is third-party tested, GMP-certified, and manufactured in a Health Canada-approved facility, ensuring consistent quality and purity. The formulations are also non-GMO, vegan, gluten-free, and use natural mixed berry flavoring with no artificial additives.

For those focused on cardiovascular health alongside sleep optimization, the superior bioavailability of liposomal melatonin means you can potentially achieve melatonin's blood pressure-regulating benefits—typically seen at 2.5–10 mg in clinical studies—with smaller effective doses. BioAbsorb's liquid format at $29.99 for 100 servings ($0.30/serving) also provides better value per gram of bioavailable melatonin than standard tablets. Combined with consistent use over 3–4 weeks as outlined in clinical research, liposomal melatonin represents a scientifically-supported approach to supporting both sleep quality and cardiovascular function.

FAQ: Melatonin and Blood Pressure

Q: Does melatonin lower or raise blood pressure?

A: For most people, especially those with hypertension, melatonin lowers blood pressure—but only with consistent, repeated dosing. Studies show reductions of 3–6 mm Hg systolic and 3–4 mm Hg diastolic with 2.5–10 mg daily for 3+ weeks. However, if you're on calcium channel blocker medications, melatonin may interfere and raise your BP instead. Always discuss with your doctor first.

Q: How much melatonin should I take for blood pressure?

A: Clinical trials used doses between 2.5 mg and 10 mg daily, with most showing effects at 3+ weeks of consistent use. There is no universally "optimal" dose—individual response varies. Start with a lower dose and increase gradually under medical supervision, particularly if you're on blood pressure medication.

Q: When should I take melatonin to affect blood pressure?

A: Take melatonin approximately 1 hour before bedtime to align with your natural circadian rhythm and maximize its blood pressure-regulating effect during sleep, when BP naturally dips. Timing consistency matters for cumulative effects over weeks.

Q: Is melatonin safe for people with high blood pressure?

A: For most people with hypertension, yes—melatonin appears safe and may provide modest blood pressure reduction. However, avoid combining it with calcium channel blocker medications without medical supervision, as it may interfere with medication efficacy. Consult your doctor before combining melatonin with any blood pressure medication.

Q: Will melatonin affect my blood pressure if I have normal BP?

A: Yes—studies in normotensive subjects show modest reductions in nighttime systolic BP of approximately 4–5 mm Hg after 3–4 weeks, though effects are generally smaller than in hypertensive populations. This modest reduction may contribute to long-term cardiovascular health even if you don't have high blood pressure.

Conclusion: Melatonin's Role in Cardiovascular Health

The evidence is clear: melatonin does affect blood pressure, with meta-analytic evidence supporting reductions of 3–3.5 mm Hg in systolic and diastolic pressure across diverse populations. For those with hypertension, the effect is more pronounced; for healthy adults, it's modest but potentially meaningful over time. The key factors are consistency—daily use for at least 3–4 weeks—appropriate timing (bedtime), and dose (2.5–10 mg, individualized). If you have hypertension, are interested in supporting your cardiovascular health through sleep optimization, or want to explore melatonin's vasodilatory mechanisms, discussing a trial period with your healthcare provider is worthwhile. Be direct about any blood pressure medications you're taking, especially calcium channel blockers, to avoid unwanted interactions.

Research References

  1. Sitzoglou K, Karatzi K, Christoforidis G, et al. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension. 2003;41:1060–1077. doi:10.1161/01.hyp.0000113293.15186.3b
  2. Johnson C, et al. The Effect of Melatonin Supplement on High Arterial Blood Pressure: An Overview from Clinicaltrials.gov. PMC National Center for Biotechnology Information. 2024.
  3. Smith JM, Petersen T, Gørst-Rasmussen A, et al. Effects of melatonin on blood pressure, arterial stiffness and quality of life in postmenopausal women. Maturitas. 2024;181:115–122.
  4. Southerland JH, et al. Melatonin supplementation reduces nighttime blood pressure but does not affect blood pressure reactivity in normotensive adults on a high-sodium diet. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2023;325:R506–R515. doi:10.1152/ajpregu.00101.2023
  5. Lusardi P, Piazza E, Fogari R. Effect of bedtime melatonin ingestion on blood pressure of normotensive subjects. Cardiovascular Drugs and Therapy. 2000;14(3):221–226.
  6. Lusardi P, Piazza E, Fogari R. Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine. British Journal of Clinical Pharmacology. 2000;49(5):423–427. doi:10.1046/j.1365-2125.2000.00167.x
  7. Khaledi M, Haghighatdoost F, Feizi A, Iraj B. Effects of Melatonin Supplementation On Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Human Hypertension. 2018;32(5):375–381. doi:10.1038/s41371-018-0059-9
  8. Jamali-Khoshalani A, Asbaghi O, Mirhosseini SH, et al. The effects of melatonin supplementation on blood pressure in patients with metabolic disorders: a systematic review and meta-analysis. Journal of Human Hypertension. 2019;33:829–838. doi:10.1038/s41371-019-0166-2
  9. Reiter RJ, Sharma R, Ma Q. Melatonin and Vascular Function. Antioxidants. 2024;13(6):747. doi:10.3390/antiox13060747
  10. Wang RX, et al. Melatonin mediates vasodilation through both direct and indirect activation of BKCa channels. Journal of Molecular Endocrinology. 2017;59(3):R29–R41. doi:10.1530/JME-17-0028
  11. Tamura EK, Burgos MG, Silva CL, Markus RP. Melatonin inhibits nitric oxide production by microvascular endothelial cells in vivo and in vitro. Journal of Pineal Research. 2006;41(3):267–274. doi:10.1111/j.1600-079X.2006.00366.x
  12. Mayo Clinic. Melatonin: Uses, Side Effects, Interactions, Dosage, and More. Accessed 2024. https://www.mayoclinic.org/drugs-supplements-melatonin/art-20363071

About the Author

This article was researched and written by the BioAbsorb content team using peer-reviewed clinical research, systematic reviews, and evidence-based nutritional science. BioAbsorb Nutraceuticals is committed to providing transparent, evidence-driven health information to support informed decision-making about supplements and cardiovascular wellness.

MEDICAL DISCLAIMER

This article is for informational purposes only and should not be construed as medical advice, a diagnosis, or a recommendation to treat, cure, mitigate, or prevent any disease or health condition. The information presented is based on published research but does not constitute professional medical advice. Always consult with a qualified healthcare provider before starting any new supplement regimen, particularly if you have pre-existing cardiovascular conditions, take blood pressure medications, or have a family history of hypertension. Individual responses to supplements vary significantly and depend on age, sex, health status, medications, and other factors. Your healthcare provider can assess whether melatonin supplementation is appropriate for your specific situation and monitor for potential drug interactions.

FDA DISCLAIMER

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Melatonin is classified as a dietary supplement under the Dietary Supplement Health and Education Act (DSHEA). The FDA does not regulate dietary supplements with the same rigor as pharmaceutical drugs. While melatonin supplements are available over-the-counter in the United States, the quality, purity, and potency may vary among manufacturers. Always purchase from reputable sources and verify third-party testing.

HEALTH CANADA DISCLAIMER

Melatonin is a natural health product licensed by Health Canada under the Natural and Non-prescription Health Products Directorate (NNHPD). Health Canada does not verify all claims made about natural health products to the same extent as pharmaceutical drugs. Users should review the product license number and detailed product information available from Health Canada's Licensed Natural Health Products Database (LNHPD) to verify regulatory status. If you are a Canadian resident, ensure any supplement you use carries a valid Natural Product Number (NPN) or Homeopathic Medicine Number (DIN-HM).

Back to Melatonin